No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations

scientific article published on August 1, 2010

No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/HUP.1136
P8608Fatcat IDrelease_ertr3dxjfzdnzcgjuovaug4ggq
P953full work available at URLhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhup.1136
https://onlinelibrary.wiley.com/doi/pdf/10.1002/hup.1136
P698PubMed publication ID20725911

P50authorNobuhisa UedaQ114366296
Asuka KatsukiQ114366299
Yuki KodamaQ88481906
Atsuko Ikenouchi-SugitaQ94449785
Hikaru HoriQ98944171
Wakako Umene-NakanoQ107749587
Reiji YoshimuraQ107749594
Jun NakamuraQ107749597
P2093author name stringKenji Hayashi
Kyoko Miyamoto
P2860cites workA rating scale for depressionQ24564540
The assessment of anxiety states by ratingQ29614719
Treatment non-adherence in affective disorders.Q34592227
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive reviewQ35054424
Enhancing medication adherence in patients with bipolar disorderQ37664710
The role of the primary care physician in patients' adherence to antidepressant therapy.Q40570973
Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levelsQ43194001
Evaluating the economic consequences of early antidepressant treatment discontinuation: a comparison between controlled-release and immediate-release paroxetine.Q45045046
An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitorsQ46507541
Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patientsQ48188457
Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depressionQ48381109
The association between concurrent psychotropic medications and self-reported adherence with taking a mood stabilizer in bipolar disorder.Q50714479
Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes.Q51919897
Depression: treatment compliance in general practice.Q52102988
Medication compliance in epilepsyQ67954917
Effects of acute paroxetine treatment on the consumption of cigarette smoking and caffeine in depressed patientsQ80861538
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)487-490
P577publication date2010-08-01
P1433published inHuman PsychopharmacologyQ15751477
P1476titleNo difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations
P478volume25

Reverse relations

Q34547958Determination of paroxetine in serum treated with simple pretreatment by pre-column high-performance liquid chromatography using 4-(5,6-dimethoxy-2-phthalimidinyl)-2-methoxyphenylsulfonyl chloride as a fluorescent labeling reagentcites workP2860

Search more.